Limitations, agreements, and source contact

Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS · Source last updated 2019-12-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

The highest dose achieved was 28 Gy but none of the patients experienced a DLT. Thus, the MTD was not reached.

point Of Contact

email

bsandmai@fredhtuch.org

organization

Fred Hutchinson Cancer Research Center

phone

(206) 667-4961

title

Brenda Sandmaier, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice